Evome Medical Technologies Inc.
LNDZF
$0.0112
-$0.0488-81.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 33.36M | 40.55M | 45.25M | 44.49M | 41.66M |
| Total Revenue | 33.36M | 40.55M | 45.25M | 44.49M | 41.66M |
| Cost of Revenue | 36.74M | 44.18M | 49.53M | 47.20M | 44.80M |
| Gross Profit | -3.38M | -3.62M | -4.27M | -2.71M | -3.13M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 2.86M | 3.15M | 3.42M | 3.34M | 3.04M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.60M | 47.33M | 52.94M | 50.54M | 47.83M |
| Operating Income | -6.24M | -6.78M | -7.69M | -6.05M | -6.17M |
| Income Before Tax | -17.30M | -14.22M | -13.39M | -11.41M | -6.12M |
| Income Tax Expenses | 15.20K | 22.30K | 15.40K | 42.20K | -2.58M |
| Earnings from Continuing Operations | -17.31 | -14.24 | -13.40 | -11.45 | -3.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.31M | -14.24M | -13.40M | -11.45M | -3.54M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.21 | -0.17 | -0.17 | -0.15 | -0.06 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.04 | -0.06 |
| EPS Diluted | -0.21 | -0.17 | -0.17 | -0.15 | -0.06 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.04 | -0.06 |
| Average Basic Shares Outstanding | 347.76M | 334.57M | 311.59M | 287.92M | 268.96M |
| Average Diluted Shares Outstanding | 347.76M | 334.57M | 311.59M | 287.92M | 268.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
